Shopping Cart
- Remove All
- Your shopping cart is currently empty
Navitoclax-piperazine (ABT-263-piperazine) is a B-cell lymphoma extra large (BCL-XL) inhibitor.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $158 | In Stock | |
5 mg | $324 | In Stock | |
10 mg | $550 | In Stock | |
25 mg | $868 | In Stock | |
50 mg | $1,190 | In Stock | |
100 mg | $1,610 | In Stock | |
1 mL x 10 mM (in DMSO) | $560 | In Stock |
Description | Navitoclax-piperazine (ABT-263-piperazine) is a B-cell lymphoma extra large (BCL-XL) inhibitor. |
Alias | ABT-263-piperazine |
Molecular Weight | 973.63 |
Formula | C47H56ClF3N6O5S3 |
Cas No. | 2143096-93-7 |
Smiles | CC1(C)CCC(=C(CN2CCN(CC2)c2ccc(cc2)C(=O)NS(=O)(=O)c2ccc(N[C@H](CCN3CCNCC3)CSc3ccccc3)c(c2)S(=O)(=O)C(F)(F)F)C1)c1ccc(Cl)cc1 |
Relative Density. | 1.41 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 250 mg/mL (256.77 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.